{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T10:20:32Z","timestamp":1791109232154,"version":"4.1.0"},"reference-count":53,"publisher":"Wiley","issue":"7","license":[{"start":{"date-parts":[[2007,1,16]],"date-time":"2007-01-16T00:00:00Z","timestamp":1168905600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Aliment Pharmacol Ther"],"published-print":{"date-parts":[[2007,4]]},"abstract":"<jats:sec><jats:title>Summary<\/jats:title><\/jats:sec><jats:sec><jats:title>Aim<\/jats:title><jats:p>To evaluate the efficacy and safety of adalimumab, a human antitumour necrosis factor\u2010\u03b1 antibody, in induction and maintenance of remission in patients with Crohn\u2019s disease either refractory or intolerant to infliximab in a single centre cohort.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Sixteen Crohn\u2019s disease patients received 160\u2003mg adalimumab subcutaneously in week 0, followed by 80\u2003mg every other week. Clinical response was assessed based on Crohn\u2019s disease activity index and laboratory parameters (leukocyte count, C\u2010reactive protein). In all patients genotyping for <jats:italic>CARD15<\/jats:italic> variants and the +1059G\/C polymorphism in the C\u2010reactive protein gene was performed.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>In 10 of 16 patients (63%) treated with adalimumab, remission (CDAI score &lt;150) was induced for at least 8\u2003weeks independent of <jats:italic>CARD15<\/jats:italic> or +1059G\/C <jats:italic>CRP<\/jats:italic> status. In six of these 10 patients ongoing remission is observed now for more than 24\u2003weeks. Adalimumab significantly decreased C\u2010reactive protein serum levels and Crohn\u2019s disease activity index. There was one serious complication (fungal pneumonia). Six patients intermittently developed minor dermatological problems resolving after topical therapy. Otherwise, treatment was generally well tolerated.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>Adalimumab can induce and maintain remission in patients with moderate to severe Crohn\u2019s disease intolerant or refractory to infliximab. Further experience from larger cohorts is required to evaluate dose regimen and safety profiles in Crohn\u2019s disease therapy.<\/jats:p><\/jats:sec>","DOI":"10.1111\/j.1365-2036.2007.03253.x","type":"journal-article","created":{"date-parts":[[2010,7,23]],"date-time":"2010-07-23T10:45:56Z","timestamp":1279881956000},"page":"787-796","source":"Crossref","is-referenced-by-count":32,"title":["Adalimumab in patients with Crohn\u2019s disease \u2013 safety and efficacy in an open\u2010label single centre study"],"prefix":"10.1111","volume":"25","author":[{"given":"J.","family":"SEIDERER","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"BRAND","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"DAMBACHER","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"PFENNIG","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"J\u00dcRGENS","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"G\u00d6KE","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"OCHSENK\u00dcHN","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2007,1,16]]},"reference":[{"key":"e_1_2_6_2_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra020831"},{"key":"e_1_2_6_3_2","doi-asserted-by":"crossref","first-page":"6276","DOI":"10.4049\/jimmunol.159.12.6276","article-title":"A role for TNF alpha and mucosal T helper\u20101 cytokines in the pathogenesis of Crohn\u2019s disease","volume":"159","author":"Plevy SE","year":"1997","journal-title":"J Immunol"},{"key":"e_1_2_6_4_2","doi-asserted-by":"publisher","DOI":"10.1136\/gut.39.5.684"},{"key":"e_1_2_6_5_2","doi-asserted-by":"publisher","DOI":"10.1006\/cyto.1995.0029"},{"key":"e_1_2_6_6_2","doi-asserted-by":"publisher","DOI":"10.1053\/gast.2000.18160"},{"key":"e_1_2_6_7_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199710093371502"},{"key":"e_1_2_6_8_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(02)08512-4"},{"key":"e_1_2_6_9_2","doi-asserted-by":"publisher","DOI":"10.1136\/gut.50.2.206"},{"key":"e_1_2_6_10_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199905063401804"},{"key":"e_1_2_6_11_2","doi-asserted-by":"publisher","DOI":"10.1097\/00042737-200411000-00014"},{"key":"e_1_2_6_12_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa050516"},{"key":"e_1_2_6_13_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM200305223482121"},{"key":"e_1_2_6_14_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa020888"},{"key":"e_1_2_6_15_2","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2003.10.047"},{"key":"e_1_2_6_16_2","doi-asserted-by":"publisher","DOI":"10.1159\/000080075"},{"key":"e_1_2_6_17_2","doi-asserted-by":"publisher","DOI":"10.1002\/art.21306"},{"key":"e_1_2_6_18_2","first-page":"1075","article-title":"Adalimumab for treating rheumatoid arthritis","volume":"33","author":"Navarro\u2010Sarabia F","year":"2006","journal-title":"J Rheumatol"},{"key":"e_1_2_6_19_2","doi-asserted-by":"publisher","DOI":"10.1002\/art.21913"},{"key":"e_1_2_6_20_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1440-1746.2005.03848.x"},{"key":"e_1_2_6_21_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.2005.40647.x"},{"key":"e_1_2_6_22_2","doi-asserted-by":"publisher","DOI":"10.1097\/00054725-200407000-00002"},{"key":"e_1_2_6_23_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.2004.40462.x"},{"key":"e_1_2_6_24_2","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2005.11.030"},{"key":"e_1_2_6_25_2","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2006.11.041"},{"key":"e_1_2_6_26_2","doi-asserted-by":"publisher","DOI":"10.3109\/00365528909091339"},{"key":"e_1_2_6_27_2","doi-asserted-by":"publisher","DOI":"10.1002\/ibd.3780060103"},{"key":"e_1_2_6_28_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0016-5085(76)80163-1"},{"key":"e_1_2_6_29_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00251-005-0073-2"},{"key":"e_1_2_6_30_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2036.2006.03093.x"},{"key":"e_1_2_6_31_2","doi-asserted-by":"publisher","DOI":"10.1038\/ncpgasthep0447"},{"key":"e_1_2_6_32_2","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2005.06.064"},{"key":"e_1_2_6_33_2","doi-asserted-by":"publisher","DOI":"10.1053\/gast.2001.28674"},{"key":"e_1_2_6_34_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2006.04.022"},{"key":"e_1_2_6_35_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2036.2006.02791.x"},{"key":"e_1_2_6_36_2","first-page":"345","article-title":"Tuberculosis associated with infliximab, a tumor necrosis factor alpha\u2010neutralizing agent","volume":"11","author":"Keane J","year":"2001","journal-title":"N Engl J Med"},{"key":"e_1_2_6_37_2","doi-asserted-by":"publisher","DOI":"10.1517\/14740338.4.4.637"},{"key":"e_1_2_6_38_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.295.19.2275"},{"key":"e_1_2_6_39_2","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2005.043166"},{"key":"e_1_2_6_40_2","doi-asserted-by":"publisher","DOI":"10.1002\/art.21841"},{"key":"e_1_2_6_41_2","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/kel235"},{"key":"e_1_2_6_42_2","first-page":"1","article-title":"Tuberculous peritonitis in a patient with rheumatoid arthritis treated with adalimumab","volume":"11","author":"Gutierrez\u2010Macias A","year":"2006","journal-title":"Clin Rheumatol"},{"key":"e_1_2_6_43_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jns.2006.01.012"},{"key":"e_1_2_6_44_2","doi-asserted-by":"publisher","DOI":"10.1002\/art.20155"},{"key":"e_1_2_6_45_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2006.07195.x"},{"key":"e_1_2_6_46_2","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/kel220"},{"key":"e_1_2_6_47_2","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2005.044453"},{"key":"e_1_2_6_48_2","doi-asserted-by":"publisher","DOI":"10.1136\/gut.2005.075937"},{"key":"e_1_2_6_49_2","doi-asserted-by":"publisher","DOI":"10.1002\/art.10697"},{"key":"e_1_2_6_50_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.mib.0000235836.32176.5e"},{"key":"e_1_2_6_51_2","doi-asserted-by":"publisher","DOI":"10.1080\/00365520600703900"},{"key":"e_1_2_6_52_2","doi-asserted-by":"publisher","DOI":"10.1080\/gas.37.7.818.824"},{"key":"e_1_2_6_53_2","doi-asserted-by":"publisher","DOI":"10.1136\/gut.2003.035253"},{"key":"e_1_2_6_54_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.fpc.0000182776.57437.d8"}],"container-title":["Alimentary Pharmacology &amp; Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2036.2007.03253.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1365-2036.2007.03253.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,13]],"date-time":"2023-10-13T21:30:37Z","timestamp":1697232637000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1365-2036.2007.03253.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,1,16]]},"references-count":53,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2007,4]]}},"alternative-id":["10.1111\/j.1365-2036.2007.03253.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1365-2036.2007.03253.x","archive":["Portico"],"relation":{},"ISSN":["0269-2813","1365-2036"],"issn-type":[{"value":"0269-2813","type":"print"},{"value":"1365-2036","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,1,16]]}}}